COVID-19 Impact on Global Pharmaceutics and Novel Drug Delivery Systems Market Size, Status and Forecast 2020-2026
Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmaceutics and Novel Drug Delivery Systems market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pharmaceutics and Novel Drug Delivery Systems industry.
Based on our recent survey, we have several different scenarios about the Pharmaceutics and Novel Drug Delivery Systems YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Pharmaceutics and Novel Drug Delivery Systems will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutics and Novel Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutics and Novel Drug Delivery Systems market in terms of revenue.
Players, stakeholders, and other participants in the global Pharmaceutics and Novel Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Pharmaceutics and Novel Drug Delivery Systems market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutics and Novel Drug Delivery Systems market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutics and Novel Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutics and Novel Drug Delivery Systems market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmaceutics and Novel Drug Delivery Systems market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Pharmaceutics and Novel Drug Delivery Systems industry.
Based on our recent survey, we have several different scenarios about the Pharmaceutics and Novel Drug Delivery Systems YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Pharmaceutics and Novel Drug Delivery Systems will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutics and Novel Drug Delivery Systems market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutics and Novel Drug Delivery Systems market in terms of revenue.
Players, stakeholders, and other participants in the global Pharmaceutics and Novel Drug Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Pharmaceutics and Novel Drug Delivery Systems market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutics and Novel Drug Delivery Systems market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutics and Novel Drug Delivery Systems market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutics and Novel Drug Delivery Systems market.
The following players are covered in this report:
- Amgen
- Teva
- Roche
- UCB (Union Chimique Belge)
- Celgene
- Merck
- Gilead Sciences
- Sanofi
- Pfizer
- Takeda
- Bausch&Lomb
- Samyang Biopharmaceuticals
- Johnson & Johnson
- TOLMAR
- Astellas
- AMAG Pharmaceuticals
- AbbVie
- Dr Reddy
- AstraZeneca
- Aspen
- Acrotech Biopharma
- TWi Pharmaceuticals
- Liposomes
- PEGylated Proteins & Polypeptides
- Polymer Nanoparticle
- Protein–drug Conjugates
- Other
- Hospitals & Clinic
- Cancer Treatment Centers
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liposomes
1.4.3 PEGylated Proteins & Polypeptides
1.4.4 Polymer Nanoparticle
1.4.5 Protein–drug Conjugates
1.4.6 Other
1.5 Market by Application
1.5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinic
1.5.3 Cancer Treatment Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutics and Novel Drug Delivery Systems Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutics and Novel Drug Delivery Systems Industry
1.6.1.1 Pharmaceutics and Novel Drug Delivery Systems Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutics and Novel Drug Delivery Systems Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutics and Novel Drug Delivery Systems Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2015-2026)
2.2 Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Regions
2.2.1 Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceutics and Novel Drug Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutics and Novel Drug Delivery Systems Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Market Size
3.1.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio
3.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2019
3.3 Pharmaceutics and Novel Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2021-2026)
5 PHARMACEUTICS AND NOVEL DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
6.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
7.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
8 CHINA
8.1 China Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
8.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
9.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
10.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
11 INDIA
11.1 India Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
11.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
12.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview and Its Total Revenue
13.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction
13.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 Teva
13.2.1 Teva Company Details
13.2.2 Teva Business Overview and Its Total Revenue
13.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction
13.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.2.5 Teva Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview and Its Total Revenue
13.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction
13.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.3.5 Roche Recent Development
13.4 UCB (Union Chimique Belge)
13.4.1 UCB (Union Chimique Belge) Company Details
13.4.2 UCB (Union Chimique Belge) Business Overview and Its Total Revenue
13.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction
13.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.4.5 UCB (Union Chimique Belge) Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview and Its Total Revenue
13.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction
13.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview and Its Total Revenue
13.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction
13.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Gilead Sciences
13.7.1 Gilead Sciences Company Details
13.7.2 Gilead Sciences Business Overview and Its Total Revenue
13.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction
13.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.7.5 Gilead Sciences Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction
13.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview and Its Total Revenue
13.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction
13.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Takeda
13.10.1 Takeda Company Details
13.10.2 Takeda Business Overview and Its Total Revenue
13.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction
13.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.10.5 Takeda Recent Development
13.11 Bausch&Lomb
10.11.1 Bausch&Lomb Company Details
10.11.2 Bausch&Lomb Business Overview and Its Total Revenue
10.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction
10.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.11.5 Bausch&Lomb Recent Development
13.12 Samyang Biopharmaceuticals
10.12.1 Samyang Biopharmaceuticals Company Details
10.12.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue
10.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
10.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.12.5 Samyang Biopharmaceuticals Recent Development
13.13 Johnson & Johnson
10.13.1 Johnson & Johnson Company Details
10.13.2 Johnson & Johnson Business Overview and Its Total Revenue
10.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction
10.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.13.5 Johnson & Johnson Recent Development
13.14 TOLMAR
10.14.1 TOLMAR Company Details
10.14.2 TOLMAR Business Overview and Its Total Revenue
10.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction
10.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.14.5 TOLMAR Recent Development
13.15 Astellas
10.15.1 Astellas Company Details
10.15.2 Astellas Business Overview and Its Total Revenue
10.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction
10.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.15.5 Astellas Recent Development
13.16 AMAG Pharmaceuticals
10.16.1 AMAG Pharmaceuticals Company Details
10.16.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
10.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
10.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.16.5 AMAG Pharmaceuticals Recent Development
13.17 AbbVie
10.17.1 AbbVie Company Details
10.17.2 AbbVie Business Overview and Its Total Revenue
10.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction
10.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.17.5 AbbVie Recent Development
13.18 Dr Reddy
10.18.1 Dr Reddy Company Details
10.18.2 Dr Reddy Business Overview and Its Total Revenue
10.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction
10.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.18.5 Dr Reddy Recent Development
13.19 AstraZeneca
10.19.1 AstraZeneca Company Details
10.19.2 AstraZeneca Business Overview and Its Total Revenue
10.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction
10.19.4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.19.5 AstraZeneca Recent Development
13.20 Aspen
10.20.1 Aspen Company Details
10.20.2 Aspen Business Overview and Its Total Revenue
10.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction
10.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.20.5 Aspen Recent Development
13.21 Acrotech Biopharma
10.21.1 Acrotech Biopharma Company Details
10.21.2 Acrotech Biopharma Business Overview and Its Total Revenue
10.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction
10.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.21.5 Acrotech Biopharma Recent Development
13.22 TWi Pharmaceuticals
10.22.1 TWi Pharmaceuticals Company Details
10.22.2 TWi Pharmaceuticals Business Overview and Its Total Revenue
10.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
10.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.22.5 TWi Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liposomes
1.4.3 PEGylated Proteins & Polypeptides
1.4.4 Polymer Nanoparticle
1.4.5 Protein–drug Conjugates
1.4.6 Other
1.5 Market by Application
1.5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 Hospitals & Clinic
1.5.3 Cancer Treatment Centers
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Pharmaceutics and Novel Drug Delivery Systems Industry Impact
1.6.1 How the Covid-19 is Affecting the Pharmaceutics and Novel Drug Delivery Systems Industry
1.6.1.1 Pharmaceutics and Novel Drug Delivery Systems Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Pharmaceutics and Novel Drug Delivery Systems Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Pharmaceutics and Novel Drug Delivery Systems Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2015-2026)
2.2 Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Regions
2.2.1 Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmaceutics and Novel Drug Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmaceutics and Novel Drug Delivery Systems Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Market Size
3.1.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio
3.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2019
3.3 Pharmaceutics and Novel Drug Delivery Systems Key Players Head office and Area Served
3.4 Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
3.5 Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2021-2026)
5 PHARMACEUTICS AND NOVEL DRUG DELIVERY SYSTEMS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
6.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in North America (2019-2020)
6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
7.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
8 CHINA
8.1 China Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
8.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in China (2019-2020)
8.3 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
8.4 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
9.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
10.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
11 INDIA
11.1 India Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
11.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in India (2019-2020)
11.3 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
11.4 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
12.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Amgen
13.1.1 Amgen Company Details
13.1.2 Amgen Business Overview and Its Total Revenue
13.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction
13.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020))
13.1.5 Amgen Recent Development
13.2 Teva
13.2.1 Teva Company Details
13.2.2 Teva Business Overview and Its Total Revenue
13.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction
13.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.2.5 Teva Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview and Its Total Revenue
13.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction
13.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.3.5 Roche Recent Development
13.4 UCB (Union Chimique Belge)
13.4.1 UCB (Union Chimique Belge) Company Details
13.4.2 UCB (Union Chimique Belge) Business Overview and Its Total Revenue
13.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction
13.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.4.5 UCB (Union Chimique Belge) Recent Development
13.5 Celgene
13.5.1 Celgene Company Details
13.5.2 Celgene Business Overview and Its Total Revenue
13.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction
13.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.5.5 Celgene Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview and Its Total Revenue
13.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction
13.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Gilead Sciences
13.7.1 Gilead Sciences Company Details
13.7.2 Gilead Sciences Business Overview and Its Total Revenue
13.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction
13.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.7.5 Gilead Sciences Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction
13.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Pfizer
13.9.1 Pfizer Company Details
13.9.2 Pfizer Business Overview and Its Total Revenue
13.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction
13.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.9.5 Pfizer Recent Development
13.10 Takeda
13.10.1 Takeda Company Details
13.10.2 Takeda Business Overview and Its Total Revenue
13.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction
13.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
13.10.5 Takeda Recent Development
13.11 Bausch&Lomb
10.11.1 Bausch&Lomb Company Details
10.11.2 Bausch&Lomb Business Overview and Its Total Revenue
10.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction
10.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.11.5 Bausch&Lomb Recent Development
13.12 Samyang Biopharmaceuticals
10.12.1 Samyang Biopharmaceuticals Company Details
10.12.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue
10.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
10.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.12.5 Samyang Biopharmaceuticals Recent Development
13.13 Johnson & Johnson
10.13.1 Johnson & Johnson Company Details
10.13.2 Johnson & Johnson Business Overview and Its Total Revenue
10.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction
10.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.13.5 Johnson & Johnson Recent Development
13.14 TOLMAR
10.14.1 TOLMAR Company Details
10.14.2 TOLMAR Business Overview and Its Total Revenue
10.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction
10.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.14.5 TOLMAR Recent Development
13.15 Astellas
10.15.1 Astellas Company Details
10.15.2 Astellas Business Overview and Its Total Revenue
10.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction
10.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.15.5 Astellas Recent Development
13.16 AMAG Pharmaceuticals
10.16.1 AMAG Pharmaceuticals Company Details
10.16.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
10.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
10.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.16.5 AMAG Pharmaceuticals Recent Development
13.17 AbbVie
10.17.1 AbbVie Company Details
10.17.2 AbbVie Business Overview and Its Total Revenue
10.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction
10.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.17.5 AbbVie Recent Development
13.18 Dr Reddy
10.18.1 Dr Reddy Company Details
10.18.2 Dr Reddy Business Overview and Its Total Revenue
10.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction
10.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.18.5 Dr Reddy Recent Development
13.19 AstraZeneca
10.19.1 AstraZeneca Company Details
10.19.2 AstraZeneca Business Overview and Its Total Revenue
10.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction
10.19.4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.19.5 AstraZeneca Recent Development
13.20 Aspen
10.20.1 Aspen Company Details
10.20.2 Aspen Business Overview and Its Total Revenue
10.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction
10.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.20.5 Aspen Recent Development
13.21 Acrotech Biopharma
10.21.1 Acrotech Biopharma Company Details
10.21.2 Acrotech Biopharma Business Overview and Its Total Revenue
10.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction
10.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.21.5 Acrotech Biopharma Recent Development
13.22 TWi Pharmaceuticals
10.22.1 TWi Pharmaceuticals Company Details
10.22.2 TWi Pharmaceuticals Business Overview and Its Total Revenue
10.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
10.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
10.22.5 TWi Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Pharmaceutics and Novel Drug Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue
Table 3. Ranking of Global Top Pharmaceutics and Novel Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposomes
Table 6. Key Players of PEGylated Proteins & Polypeptides
Table 7. Key Players of Polymer Nanoparticle
Table 8. Key Players of Protein–drug Conjugates
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Pharmaceutics and Novel Drug Delivery Systems Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Pharmaceutics and Novel Drug Delivery Systems Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Pharmaceutics and Novel Drug Delivery Systems Players to Combat Covid-19 Impact
Table 15. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2015-2020)
Table 19. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Pharmaceutics and Novel Drug Delivery Systems Market Growth Strategy
Table 25. Main Points Interviewed from Key Pharmaceutics and Novel Drug Delivery Systems Players
Table 26. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 27. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players (2015-2020)
Table 28. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2019)
Table 29. Global Pharmaceutics and Novel Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
Table 32. Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 35. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Type (2015-2020)
Table 36. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2021-2026)
Table 37. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2015-2020)
Table 38. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 39. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2021-2026)
Table 40. North America Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 42. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 43. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 44. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 45. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 46. Europe Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 48. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 50. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 52. China Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 53. China Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 54. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 55. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 56. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 57. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 58. Japan Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 60. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 62. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 66. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 68. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 70. India Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 71. India Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 72. India Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 73. India Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 74. India Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 75. India Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 78. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 80. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Product
Table 85. Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 86. Amgen Recent Development
Table 87. Teva Company Details
Table 88. Teva Business Overview
Table 89. Teva Product
Table 90. Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 91. Teva Recent Development
Table 92. Roche Company Details
Table 93. Roche Business Overview
Table 94. Roche Product
Table 95. Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 96. Roche Recent Development
Table 97. UCB (Union Chimique Belge) Company Details
Table 98. UCB (Union Chimique Belge) Business Overview
Table 99. UCB (Union Chimique Belge) Product
Table 100. UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 101. UCB (Union Chimique Belge) Recent Development
Table 102. Celgene Company Details
Table 103. Celgene Business Overview
Table 104. Celgene Product
Table 105. Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 106. Celgene Recent Development
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Product
Table 110. Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 111. Merck Recent Development
Table 112. Gilead Sciences Company Details
Table 113. Gilead Sciences Business Overview
Table 114. Gilead Sciences Product
Table 115. Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 116. Gilead Sciences Recent Development
Table 117. Sanofi Business Overview
Table 118. Sanofi Product
Table 119. Sanofi Company Details
Table 120. Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 121. Sanofi Recent Development
Table 122. Pfizer Company Details
Table 123. Pfizer Business Overview
Table 124. Pfizer Product
Table 125. Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 126. Pfizer Recent Development
Table 127. Takeda Company Details
Table 128. Takeda Business Overview
Table 129. Takeda Product
Table 130. Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 131. Takeda Recent Development
Table 132. Bausch&Lomb Company Details
Table 133. Bausch&Lomb Business Overview
Table 134. Bausch&Lomb Product
Table 135. Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 136. Bausch&Lomb Recent Development
Table 137. Samyang Biopharmaceuticals Company Details
Table 138. Samyang Biopharmaceuticals Business Overview
Table 139. Samyang Biopharmaceuticals Product
Table 140. Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 141. Samyang Biopharmaceuticals Recent Development
Table 142. Johnson & Johnson Company Details
Table 143. Johnson & Johnson Business Overview
Table 144. Johnson & Johnson Product
Table 145. Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 146. Johnson & Johnson Recent Development
Table 147. TOLMAR Company Details
Table 148. TOLMAR Business Overview
Table 149. TOLMAR Product
Table 150. TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 151. TOLMAR Recent Development
Table 152. Astellas Company Details
Table 153. Astellas Business Overview
Table 154. Astellas Product
Table 155. Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 156. Astellas Recent Development
Table 157. AMAG Pharmaceuticals Company Details
Table 158. AMAG Pharmaceuticals Business Overview
Table 159. AMAG Pharmaceuticals Product
Table 160. AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 161. AMAG Pharmaceuticals Recent Development
Table 162. AbbVie Company Details
Table 163. AbbVie Business Overview
Table 164. AbbVie Product
Table 165. AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 166. AbbVie Recent Development
Table 167. Dr Reddy Company Details
Table 168. Dr Reddy Business Overview
Table 169. Dr Reddy Product
Table 170. Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 171. Dr Reddy Recent Development
Table 172. AstraZeneca Company Details
Table 173. AstraZeneca Business Overview
Table 174. AstraZeneca Product
Table 175. AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 176. AstraZeneca Recent Development
Table 177. Aspen Company Details
Table 178. Aspen Business Overview
Table 179. Aspen Product
Table 180. Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 181. Aspen Recent Development
Table 182. Acrotech Biopharma Company Details
Table 183. Acrotech Biopharma Business Overview
Table 184. Acrotech Biopharma Product
Table 185. Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 186. Acrotech Biopharma Recent Development
Table 187. TWi Pharmaceuticals Company Details
Table 188. TWi Pharmaceuticals Business Overview
Table 189. TWi Pharmaceuticals Product
Table 190. TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 191. TWi Pharmaceuticals Recent Development
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
Table 1. Pharmaceutics and Novel Drug Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue
Table 3. Ranking of Global Top Pharmaceutics and Novel Drug Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposomes
Table 6. Key Players of PEGylated Proteins & Polypeptides
Table 7. Key Players of Polymer Nanoparticle
Table 8. Key Players of Protein–drug Conjugates
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Pharmaceutics and Novel Drug Delivery Systems Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Pharmaceutics and Novel Drug Delivery Systems Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Pharmaceutics and Novel Drug Delivery Systems Players to Combat Covid-19 Impact
Table 15. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2015-2020)
Table 19. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Pharmaceutics and Novel Drug Delivery Systems Market Growth Strategy
Table 25. Main Points Interviewed from Key Pharmaceutics and Novel Drug Delivery Systems Players
Table 26. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 27. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players (2015-2020)
Table 28. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2019)
Table 29. Global Pharmaceutics and Novel Drug Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
Table 32. Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 35. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Type (2015-2020)
Table 36. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2021-2026)
Table 37. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2015-2020)
Table 38. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 39. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Share by Application (2021-2026)
Table 40. North America Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 42. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 43. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 44. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 45. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 46. Europe Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 48. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 50. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 52. China Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 53. China Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 54. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 55. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 56. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 57. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 58. Japan Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 60. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 62. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 66. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 68. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 70. India Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 71. India Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 72. India Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 73. India Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 74. India Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 75. India Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Pharmaceutics and Novel Drug Delivery Systems Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Pharmaceutics and Novel Drug Delivery Systems Market Share (2019-2020)
Table 78. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2015-2020)
Table 80. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2015-2020)
Table 82. Amgen Company Details
Table 83. Amgen Business Overview
Table 84. Amgen Product
Table 85. Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 86. Amgen Recent Development
Table 87. Teva Company Details
Table 88. Teva Business Overview
Table 89. Teva Product
Table 90. Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 91. Teva Recent Development
Table 92. Roche Company Details
Table 93. Roche Business Overview
Table 94. Roche Product
Table 95. Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 96. Roche Recent Development
Table 97. UCB (Union Chimique Belge) Company Details
Table 98. UCB (Union Chimique Belge) Business Overview
Table 99. UCB (Union Chimique Belge) Product
Table 100. UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 101. UCB (Union Chimique Belge) Recent Development
Table 102. Celgene Company Details
Table 103. Celgene Business Overview
Table 104. Celgene Product
Table 105. Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 106. Celgene Recent Development
Table 107. Merck Company Details
Table 108. Merck Business Overview
Table 109. Merck Product
Table 110. Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 111. Merck Recent Development
Table 112. Gilead Sciences Company Details
Table 113. Gilead Sciences Business Overview
Table 114. Gilead Sciences Product
Table 115. Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 116. Gilead Sciences Recent Development
Table 117. Sanofi Business Overview
Table 118. Sanofi Product
Table 119. Sanofi Company Details
Table 120. Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 121. Sanofi Recent Development
Table 122. Pfizer Company Details
Table 123. Pfizer Business Overview
Table 124. Pfizer Product
Table 125. Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 126. Pfizer Recent Development
Table 127. Takeda Company Details
Table 128. Takeda Business Overview
Table 129. Takeda Product
Table 130. Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 131. Takeda Recent Development
Table 132. Bausch&Lomb Company Details
Table 133. Bausch&Lomb Business Overview
Table 134. Bausch&Lomb Product
Table 135. Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 136. Bausch&Lomb Recent Development
Table 137. Samyang Biopharmaceuticals Company Details
Table 138. Samyang Biopharmaceuticals Business Overview
Table 139. Samyang Biopharmaceuticals Product
Table 140. Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 141. Samyang Biopharmaceuticals Recent Development
Table 142. Johnson & Johnson Company Details
Table 143. Johnson & Johnson Business Overview
Table 144. Johnson & Johnson Product
Table 145. Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 146. Johnson & Johnson Recent Development
Table 147. TOLMAR Company Details
Table 148. TOLMAR Business Overview
Table 149. TOLMAR Product
Table 150. TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 151. TOLMAR Recent Development
Table 152. Astellas Company Details
Table 153. Astellas Business Overview
Table 154. Astellas Product
Table 155. Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 156. Astellas Recent Development
Table 157. AMAG Pharmaceuticals Company Details
Table 158. AMAG Pharmaceuticals Business Overview
Table 159. AMAG Pharmaceuticals Product
Table 160. AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 161. AMAG Pharmaceuticals Recent Development
Table 162. AbbVie Company Details
Table 163. AbbVie Business Overview
Table 164. AbbVie Product
Table 165. AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 166. AbbVie Recent Development
Table 167. Dr Reddy Company Details
Table 168. Dr Reddy Business Overview
Table 169. Dr Reddy Product
Table 170. Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 171. Dr Reddy Recent Development
Table 172. AstraZeneca Company Details
Table 173. AstraZeneca Business Overview
Table 174. AstraZeneca Product
Table 175. AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 176. AstraZeneca Recent Development
Table 177. Aspen Company Details
Table 178. Aspen Business Overview
Table 179. Aspen Product
Table 180. Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 181. Aspen Recent Development
Table 182. Acrotech Biopharma Company Details
Table 183. Acrotech Biopharma Business Overview
Table 184. Acrotech Biopharma Product
Table 185. Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 186. Acrotech Biopharma Recent Development
Table 187. TWi Pharmaceuticals Company Details
Table 188. TWi Pharmaceuticals Business Overview
Table 189. TWi Pharmaceuticals Product
Table 190. TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020) (Million US$)
Table 191. TWi Pharmaceuticals Recent Development
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Liposomes Features
Figure 3. PEGylated Proteins & Polypeptides Features
Figure 4. Polymer Nanoparticle Features
Figure 5. Protein–drug Conjugates Features
Figure 6. Other Features
Figure 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026
Figure 8. Hospitals & Clinic Case Studies
Figure 9. Cancer Treatment Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Pharmaceutics and Novel Drug Delivery Systems Report Years Considered
Figure 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players in 2019
Figure 17. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2019
Figure 19. North America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 28. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Teva Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 32. UCB (Union Chimique Belge) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. UCB (Union Chimique Belge) Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 34. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Celgene Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 36. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Merck Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 38. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Gilead Sciences Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 44. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Takeda Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 46. Bausch&Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Bausch&Lomb Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 48. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Samyang Biopharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Johnson & Johnson Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 52. TOLMAR Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. TOLMAR Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 54. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Astellas Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 56. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. AMAG Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 58. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. AbbVie Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 60. Dr Reddy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Dr Reddy Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 62. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. AstraZeneca Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 64. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Aspen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Figure 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Liposomes Features
Figure 3. PEGylated Proteins & Polypeptides Features
Figure 4. Polymer Nanoparticle Features
Figure 5. Protein–drug Conjugates Features
Figure 6. Other Features
Figure 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026
Figure 8. Hospitals & Clinic Case Studies
Figure 9. Cancer Treatment Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Pharmaceutics and Novel Drug Delivery Systems Report Years Considered
Figure 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players in 2019
Figure 17. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2019
Figure 19. North America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Amgen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 28. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Teva Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 32. UCB (Union Chimique Belge) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. UCB (Union Chimique Belge) Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 34. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Celgene Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 36. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Merck Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 38. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Gilead Sciences Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 40. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Sanofi Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 44. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Takeda Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 46. Bausch&Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Bausch&Lomb Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 48. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Samyang Biopharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Johnson & Johnson Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 52. TOLMAR Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. TOLMAR Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 54. Astellas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Astellas Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 56. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. AMAG Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 58. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. AbbVie Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 60. Dr Reddy Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Dr Reddy Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 62. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. AstraZeneca Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 64. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Aspen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
